⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Identification of High Risk People for Colorectal Cancer and Evaluation of a Specific Surveillance System

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Identification of High Risk People for Colorectal Cancer and Evaluation of a Specific Surveillance System

Official Title: Identification of High Risk People for Colorectal Cancer in Indre-et-Loire (France) and Evaluation of a Specific Surveillance System : a Randomized Trial Assessing the Efficacy of a Letter Encouraging People to Perform Colonoscopy Screening

Study ID: NCT02931825

Interventions

Reminder letter

Study Description

Brief Summary: Colorectal cancer is one the most frequent cancer in developed countries. In France, it rank third with 43000 new cases in 2015. French Health Authority recommended colonoscopy screening for people with a high risk for colorectal cancer. But this compliance with colonoscopy is low (20-40%), it is therefore necessary to develop new strategies to improve compliance. The purpose of this project is to to offer and evaluate the feasibility and the effectiveness of a specific surveillance system for high risk people for colorectal cancer The project will be divided into 2 phases: Objectives of the first phase: * Identify high risk people for colorectal cancer in the department of Indre-et-Loire, * Fill in as completely as possible their colonoscopic history in the past 5 years, * Estimate the proportion of high risk people for colorectal cancer in the target population for colorectal cancer screening in Indre-et-Loire (Men and women aged from 50 to 74 years). Objective of the second phase: Compare the performed colonoscopy rate of high risk people for colorectal cancer without notion of colonoscopy in the past 58 months following or not (control group) the sending of a letter reminding the importance of compliance with colonoscopy.

Detailed Description:

Eligibility

Minimum Age: 50 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

UH Tours, Tours, Indre-et-Loire, France

Contact Details

Name: Somany SENGCHANH, Dr

Affiliation: Centre de Coordination des Dépistages des Cancers CHRU de Tours

Role: PRINCIPAL_INVESTIGATOR

Name: Ken HAGUENOER, Dr

Affiliation: Centre de Coordination des Dépistages des Cancers

Role: PRINCIPAL_INVESTIGATOR

Name: Julie Boyard

Affiliation: Centre de Coordination des Dépistages des Cancers

Role: PRINCIPAL_INVESTIGATOR

Name: Thierry Lecomte, Pr

Affiliation: CHRU de Tours, Service Hépato- gastroentérologie

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: